Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTTI steering committee appoints at-large member

This article was originally published in SRA

Norman Fost has been selected as the at-large member of the steering committee of the US Clinical Trials Transformation Initiative, the public-private partnership aimed at modernising the way clinical trials are conducted that was launched by the Food and Drug Administration and Duke University in 2007.

Dr Fost is a professor of paediatrics and of medical history and bioethics at the University of Wisconsin, and has studied, taught and written about ethical and regulatory issues relating to clinical research. Since 1984, he has been chair of the University of Wisconsin hospital ethics committee.

Dr Fost, notes the CTTI, will bring “a unique and valuable perspective” to the efforts of the initiative to improve the quality and efficiency of clinical trials.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS114672

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel